Introduction
Muscle recovery is one of the most active areas of peptide research. Several compounds have shown promise in preclinical studies for accelerating tissue repair, reducing inflammation markers, and supporting regeneration of skeletal muscle following injury. This overview covers the most studied peptides in muscle recovery research as of 2025.
BPC-157
BPC-157 is arguably the most studied peptide in musculoskeletal recovery research. Animal studies have demonstrated accelerated healing of muscle tears, tendon injuries, and ligament damage. Its proposed mechanisms include promotion of angiogenesis, upregulation of growth hormone receptors in tendon fibroblasts, and modulation of the nitric oxide system. Research in rodent models has consistently shown faster return of function following muscle injury with BPC-157 administration.
TB-500 (Thymosin Beta-4)
TB-500 has been studied for its role in systemic tissue repair through actin regulation and cell migration promotion. In skeletal muscle research, TB-500 has shown potential for reducing inflammation and supporting regeneration of damaged muscle fibers. Its systemic mechanism of action makes it a subject of interest for whole-body recovery protocols in animal research.
IGF-1 LR3
Insulin-Like Growth Factor 1 Long R3 is a potent anabolic peptide studied for its role in muscle cell proliferation and differentiation. IGF-1 LR3 has a longer half-life than native IGF-1 and has been shown in preclinical studies to support satellite cell activation — the muscle stem cells responsible for repair and growth following injury.
MGF (Mechano Growth Factor)
MGF is a splice variant of IGF-1 that is locally expressed in muscle tissue following mechanical strain or injury. Research has focused on its role in activating muscle satellite cells and initiating the repair cascade. MGF pulses appear to be an early signal in the muscle recovery process, making it a compound of interest for understanding the mechanisms of exercise-induced adaptation.
GHRP-6 and Ipamorelin
Growth hormone-releasing peptides including GHRP-6 and Ipamorelin have been studied for their downstream effects on muscle recovery through GH and IGF-1 elevation. GHRP-6 has also shown direct anti-inflammatory properties in some animal studies independent of its GH-releasing effects.
Follistatin 344
Follistatin 344 research has focused on its ability to inhibit myostatin, a protein that limits muscle growth. By reducing myostatin activity, follistatin may theoretically allow for greater muscle fiber development and recovery. Animal studies have shown significant increases in muscle mass in follistatin-treated subjects.
Conclusion
The peptide research landscape for muscle recovery is rich and evolving. BPC-157 and TB-500 remain the most referenced compounds in injury repair research, while IGF-1 LR3, MGF, and follistatin represent active areas of investigation in muscle growth and regeneration science.